Skip to content
ChickenStockChickenStock
ResearchFilings
← Disclosures

Edwards LifesciencesEW

Edwards Lifesciences 8-K

Filing date ·

The company said net sales for Q3 2026 rose to $1,715.5 million, up 10.5% from $1,553.1 million a year earlier (11.2% on a constant currency basis). TAVR sales…

Sign in to read this filing in detail

Continue to the filing details and any available analysis after signing in.

Filing lists are available without signing in.